Preferred Hotels & Resorts continues leading global travel trend by launching new partnership with UnionPay International
Program allows UnionPay global cardholders access to more than 135 hotels with 2,500 I Prefer bonus points and free member tier upgrade to Explorer BEIJING, Nov. 18, 2023 /PRNewswire/ — Preferred Hotels & Resorts, the world’s largest independent hotel brand announces its new global p
Sonic Brilliance: Navigating the Legacy of #MakingSoundVisible with Toshiba TV
HONG KONG, Nov. 18, 2023 /PRNewswire/ — Aligning with Toshiba TV’s commitment to crafting enduring models featuring dynamic sound and picture performance, the Z870 model stands out as a significant addition to its legacy. The recently concluded #MakingSoundVisible campaign surpassed the
‘Learning Mandarin in Taiwan!’ Taiwan becomes the top destination for studying Mandarin
TAIPEI, Nov. 17, 2023 /PRNewswire/ — Taiwan has become a top destination for American students to learn and study Mandarin. Taiwan’s free society, welcoming people, convenient environment, exceptional scenery, and robust healthcare system are among the many reasons why foreigners choose
Infisign Showcases Successful Interoperability for Verifiable Credential Issuance and Verification
CHENNAI, India, Nov. 18, 2023 /PRNewswire/ — Infisign, a leading Identity and Access Management (IAM) platform, proudly announces its triumphant participation in Jobs for the Future’s (JFF) PlugFest 3. The event focused on demonstrating advanced interoperability for Verifiable Credential
Global Stem Cell Collaboration and Licensing Agreements Analysis Report 2023 with Directory of 150+ Deals Signed Since 2016
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Stem Cell Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. This report contains a comprehensive listing of 158 stem cell deals announced since 2016 including financial terms wh
Global Genitourinary Collaboration and Licensing Agreement Analysis Report 2023 with Directory of Deals Signed by the World’s Leading Biopharma Companies Since 2016
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Genitourinary Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. Genitourinary Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access
Global Metabolic Collaboration and Licensing Agreements Analysis Report 2023 with Directory of Deals Signed Since 2016
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Metabolic Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. Metabolic Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the m
TSX Venture Exchange Stock Maintenance Bulletins
VANCOUVER, BC, Nov. 17, 2023 /CNW/ – TSX VENTURE COMPANIES OSISKO DEVELOPMENT CORP. (“ODV.WT”)BULLETIN TYPE: Warrant Expiry-DelistBULLETIN DATE: November 17, 2023TSX Venture Tier 1 Company Effective at the opening, November 29, 2023, the Share Purchase Warrants of the Compan
World Gynecology Collaboration and Licensing Agreements Analysis Report 2023 with Directory of Deals Signed Since 2016
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Gynecology Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. Gynecology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the
Global Immunology Collaboration and Licensing Agreements Analysis Report 2023 with Directory of Deals Signed by the World’s Leading Biopharma Companies Since 2016
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Immunology Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. Immunology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the